Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Intelgenx Technologies
(OTCQB:IGXT)
Intraday
$0.1666
0
[0.00%]
After-Hours
$0.109
-0.0576
[-34.59%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.1666
0
[0.00%]
At close: Apr 25
$0.109
-0.0576
[-34.59%]
PreMarket: 8:42AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Intelgenx Technologies Stock (OTC:IGXT)
Intelgenx Technologies Stock (OTC: IGXT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 15, 2024
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Lara Goldstein
-
Jan 15, 2024, 1:38PM
Thursday, November 09, 2023
Intelgenx Technologies Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $318.00K Up From $142.00K YoY
Benzinga Newsdesk
-
Nov 9, 2023, 4:32PM
Monday, November 06, 2023
IntelGenx Announces Co-Development And Commercialization Of Cannabinoid-Infused VersaFilm Products With Tilray
Benzinga Newsdesk
-
Nov 6, 2023, 8:34AM
Monday, August 14, 2023
IntelGenx Q2 2023: Revenue Decline 67%, Operating Costs Rise, What About Net Loss?
Nicolás Jose Rodriguez
-
Aug 14, 2023, 10:54PM
Intelgenx Technologies Q2 EPS $(0.02), Same YoY, Sales $133.00K Down From $398.00K YoY
Benzinga Newsdesk
-
Aug 14, 2023, 4:32PM
Monday, May 15, 2023
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein
-
May 15, 2023, 5:30PM
Thursday, May 11, 2023
FDA Gives Nod To IntelGenx's Migraine Solution As Revenues Plunge 32%; Q1 Results Report
Nicolás Jose Rodriguez
-
May 11, 2023, 6:33PM
Intelgenx Technologies Q1 EPS $(0.02), Same YoY, Sales $162.00K Down From $237.00K YoY
Benzinga Newsdesk
-
May 11, 2023, 4:10PM
Wednesday, April 05, 2023
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Lara Goldstein
-
Apr 5, 2023, 9:57AM
Thursday, March 30, 2023
IntelGenx's Q4 And Full-Year 2022 Financials, 'On The Cusp' Of Rapid Growth?
Lara Goldstein
-
Mar 30, 2023, 3:31PM
Intelgenx Technologies Q4 EPS $(0.01) Up From $(0.02) YoY, Sales $173.00K Down From $494.00K YoY
Happy Mohamed
-
Mar 30, 2023, 1:09AM
Tuesday, January 31, 2023
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 31, 2023, 4:30PM
Monday, January 30, 2023
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 30, 2023, 4:30PM
Friday, January 27, 2023
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 27, 2023, 4:30PM
Thursday, January 26, 2023
Psychedelic Stock Gainers And Losers From January 26, 2023
Benzinga Insights
-
Jan 26, 2023, 4:30PM
Wednesday, January 25, 2023
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 25, 2023, 4:30PM
Tuesday, January 24, 2023
Psychedelic Stock Gainers And Losers From January 24, 2023
Benzinga Insights
-
Jan 24, 2023, 4:30PM
Thursday, January 19, 2023
Psychedelic Stock Gainers And Losers From January 19, 2023
Benzinga Insights
-
Jan 19, 2023, 4:30PM
Monday, January 16, 2023
GH Research, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 16, 2023, 4:30PM
Friday, January 13, 2023
Psychedelic Stock Gainers And Losers From January 13, 2023
Benzinga Insights
-
Jan 13, 2023, 4:30PM
Thursday, January 12, 2023
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jan 12, 2023, 4:30PM
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
Lara Goldstein
-
Jan 12, 2023, 11:20AM
Thursday, November 10, 2022
IntelGenx Reports Q3 2022 Financial Results, Management Anticipates Psychedelics Trials In 2023
Nicolás Jose Rodriguez
-
Nov 10, 2022, 6:21PM
Intelgenx Technologies Q3 EPS $(0.02) Down From $(0.01) YoY, Sales $142.00K Down From $593.00K YoY
Benzinga Newsdesk
-
Nov 10, 2022, 4:14PM
Thursday, November 03, 2022
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection
Lara Goldstein
-
Nov 3, 2022, 12:47PM
Tuesday, October 25, 2022
Canadian Company's New Version Of Chemo-Induced Pain Treatment Is On FDA Track
Lara Goldstein
-
Oct 25, 2022, 1:47PM
Thursday, October 13, 2022
IntelGenx's Collaboration With ATAI Life Sciences Culminates In The Initiation Of First-In-Human Clinical Study Of An Oral Thin Film Psychedelic Drug Candidate
Benzinga Newsdesk
-
Oct 13, 2022, 9:23AM
Tuesday, October 04, 2022
Short Volatility Alert: IntelGenx Technologies Corp.
Christopher Sappo
-
Oct 4, 2022, 11:13AM
Thursday, August 11, 2022
Intelgenx Technologies Q2 EPS $(0.02), Same YoY, Sales $398.00K Up From $162.00K YoY
Benzinga Newsdesk
-
Aug 11, 2022, 5:22PM
Wednesday, August 03, 2022
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Aug 3, 2022, 4:37PM
Monday, August 01, 2022
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Aug 1, 2022, 4:58PM
Friday, July 29, 2022
Psychedelic Stock Gainers And Losers From July 29, 2022
Benzinga Insights
-
Jul 29, 2022, 5:58PM
Thursday, June 09, 2022
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 9, 2022, 5:19PM
Wednesday, June 08, 2022
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 8, 2022, 4:48PM
Tuesday, June 07, 2022
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 7, 2022, 4:56PM
Monday, June 06, 2022
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 6, 2022, 4:52PM
Friday, June 03, 2022
Psychedelic Stock Gainers And Losers From June 3, 2022
Benzinga Insights
-
Jun 3, 2022, 4:37PM
Thursday, June 02, 2022
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 2, 2022, 5:19PM
Wednesday, June 01, 2022
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga Insights
-
Jun 1, 2022, 5:00PM
Tuesday, May 31, 2022
Psychedelic Stock Gainers And Losers From May 31, 2022
Benzinga Insights
-
May 31, 2022, 4:37PM
Thursday, May 26, 2022
Psychedelic Stock Gainers And Losers From May 26, 2022
Benzinga Insights
-
May 26, 2022, 6:13PM
Wednesday, May 25, 2022
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
-
May 25, 2022, 4:45PM
Tuesday, May 24, 2022
Psychedelic Stock Gainers And Losers From May 24, 2022
Benzinga Insights
-
May 24, 2022, 5:36PM
Monday, May 23, 2022
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
-
May 23, 2022, 4:33PM
Friday, May 20, 2022
Psychedelic Stock Gainers And Losers From May 20, 2022
Benzinga Insights
-
May 20, 2022, 4:37PM
Thursday, May 19, 2022
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
-
May 19, 2022, 4:31PM
Wednesday, May 18, 2022
Cybin, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
-
May 18, 2022, 4:36PM
Tuesday, May 17, 2022
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
-
May 17, 2022, 4:34PM
Monday, May 16, 2022
Psychedelic Stock Gainers And Losers From May 16, 2022
Benzinga Insights
-
May 16, 2022, 4:49PM
Wednesday, May 11, 2022
Psychedelic Stock Gainers And Losers From May 11, 2022
Benzinga Insights
-
May 11, 2022, 4:30PM
Show more